GFAP and schizophrenia: However, the decreased GFAP mRNA in schizophrenia compared to controls overall could be due to the greater elevation of GFAP mRNA in high inflammation controls in our study, which aligns with previous studies of GFAP expression showing no change or even decreases in schizophrenia overall (Trepanier et al., 2016).